Disposition of the human immunodeficiency virus Tat inhibitor, Ro 5-3335, in rats and dogs.
Town
C
C
Department of Drug Metabolism, Hoffmann-La Roche, Inc., Nutley, NJ 07110.
Chang
D
D
Henderson
L
L
Garland
W A
WA
D000818:Animals; D000998:Antiviral Agents / Q000493:pharmacokinetics*; D001570:Benzodiazepinones / Q000493:pharmacokinetics*; D004285:Dogs; D005260:Female; D006678:HIV / Q000187:drug effects; D066298:In Vitro Techniques; D008099:Liver / Q000378:metabolism; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D011758:Pyrroles / Q000493:pharmacokinetics*; D051381:Rats; D017207:Rats, Sprague-Dawley
D000998:Antiviral Agents; D001570:Benzodiazepinones; D011758:Pyrroles; C072173:Ro 5-3335